Airborne Mycobacterium tuberculosis inactivated by advanced photohydrolysis technology.

IF 3.6 2区 医学 Q1 MICROBIOLOGY
Jennifer E Peel, Alyssa A Varghese, Reina N Paez, Sadhana Chauhan, Janice J Endsley, William S Lawrence
{"title":"Airborne Mycobacterium tuberculosis inactivated by advanced photohydrolysis technology.","authors":"Jennifer E Peel, Alyssa A Varghese, Reina N Paez, Sadhana Chauhan, Janice J Endsley, William S Lawrence","doi":"10.1186/s12941-026-00855-6","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis is a respiratory infectious disease that persists worldwide, largely due to the robustness and ease of dissemination of its causative agent, Mycobacterium tuberculosis. To mitigate the spread of infection, various measures have been developed to inactivate the bacteria in its aerosol form. Advanced photohydrolysis technology (APHT) was previously reported to inactivate both respiratory viral and bacterial pathogens; however, its efficacy against M. tuberculosis has yet to be evaluated. In this study, we assessed the ability of APHT to inactivate aerosolized M. tuberculosis. The bacteria were aerosolized into a custom chamber containing an APHT device, which was operated for 1 and 10 min after aerosolization. A control device lacking the APHT component was used for comparison. The APHT device achieved a 1.3-log<sub>10</sub> reduction (approximately 95%) in bacterial load after 1 min and a 2.26-log<sub>10</sub> reduction (over 99%) after 10 min. This study demonstrates the ability of APHT to inactivate aerosolized M. tuberculosis and supports its application as a possible effective infection control intervention.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13067662/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical Microbiology and Antimicrobials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12941-026-00855-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis is a respiratory infectious disease that persists worldwide, largely due to the robustness and ease of dissemination of its causative agent, Mycobacterium tuberculosis. To mitigate the spread of infection, various measures have been developed to inactivate the bacteria in its aerosol form. Advanced photohydrolysis technology (APHT) was previously reported to inactivate both respiratory viral and bacterial pathogens; however, its efficacy against M. tuberculosis has yet to be evaluated. In this study, we assessed the ability of APHT to inactivate aerosolized M. tuberculosis. The bacteria were aerosolized into a custom chamber containing an APHT device, which was operated for 1 and 10 min after aerosolization. A control device lacking the APHT component was used for comparison. The APHT device achieved a 1.3-log10 reduction (approximately 95%) in bacterial load after 1 min and a 2.26-log10 reduction (over 99%) after 10 min. This study demonstrates the ability of APHT to inactivate aerosolized M. tuberculosis and supports its application as a possible effective infection control intervention.

先进光水解技术灭活空气传播结核分枝杆菌。
结核病是一种在世界范围内持续存在的呼吸道传染病,主要是由于其病原体结核分枝杆菌的坚固性和易于传播。为了减轻感染的传播,已经制定了各种措施来灭活其气溶胶形式的细菌。先进的光水解技术(APHT)曾被报道可以灭活呼吸道病毒和细菌病原体;然而,它对结核分枝杆菌的疗效还有待评估。在这项研究中,我们评估了APHT灭活雾化结核分枝杆菌的能力。将细菌雾化到装有APHT装置的定制腔室中,雾化后分别操作1和10 min。采用不含APHT成分的对照装置进行比较。APHT设备在1分钟后细菌负荷减少1.3-log10(约95%),10分钟后减少2.26-log10(超过99%)。本研究证明了APHT灭活雾化结核分枝杆菌的能力,并支持其作为一种可能有效的感染控制干预措施的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.60
自引率
0.00%
发文量
49
审稿时长
>12 weeks
期刊介绍: Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance. Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases. Annals of Clinical Microbiology and Antimicrobials is an open access, peer-reviewed journal focusing on information concerning clinical microbiology, infectious diseases and antimicrobials. The management of infectious disease is dependent on correct diagnosis and appropriate antimicrobial treatment, and with this in mind, the journal aims to improve the communication between laboratory and clinical science in the field of clinical microbiology and antimicrobial treatment. Furthermore, the journal has no restrictions on space or access; this ensures that the journal can reach the widest possible audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书